BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,599,945 | +41.5% | 386,856 | +70.8% | 0.35% | +53.5% |
| Q2 2023 | $10,319,522 | +6.5% | 226,504 | -5.2% | 0.23% | +14.1% |
| Q1 2023 | $9,686,134 | +34.7% | 238,810 | +69.3% | 0.20% | +19.3% |
| Q4 2022 | $7,188,452 | +16.8% | 141,033 | +23.4% | 0.17% | +7.8% |
| Q3 2022 | $6,156,000 | -51.8% | 114,297 | -42.5% | 0.15% | -54.2% |
| Q2 2022 | $12,760,000 | +24.4% | 198,654 | +50.2% | 0.34% | +41.2% |
| Q1 2022 | $10,254,000 | +41.2% | 132,241 | +56.3% | 0.24% | +39.2% |
| Q4 2021 | $7,262,000 | +108.0% | 84,605 | +94.9% | 0.17% | +76.3% |
| Q3 2021 | $3,492,000 | +125.4% | 43,415 | +125.7% | 0.10% | +94.0% |
| Q2 2021 | $1,549,000 | +18.6% | 19,237 | +24.2% | 0.05% | +2.0% |
| Q1 2021 | $1,306,000 | +112.4% | 15,486 | +102.1% | 0.05% | +113.0% |
| Q4 2020 | $615,000 | -57.9% | 7,663 | -57.9% | 0.02% | -73.9% |
| Q3 2020 | $1,462,000 | +364.1% | 18,183 | +397.1% | 0.09% | +300.0% |
| Q2 2020 | $315,000 | -79.7% | 3,658 | -80.8% | 0.02% | -82.8% |
| Q1 2020 | $1,548,000 | -54.0% | 19,065 | -52.6% | 0.13% | -56.2% |
| Q4 2019 | $3,362,000 | +7.7% | 40,203 | +12.7% | 0.29% | +2.1% |
| Q3 2019 | $3,121,000 | +845.8% | 35,684 | +599.8% | 0.29% | +495.8% |
| Q4 2017 | $330,000 | +26.4% | 5,099 | +1.4% | 0.05% | -2.0% |
| Q1 2017 | $261,000 | +26.1% | 5,028 | +7.5% | 0.05% | +4.3% |
| Q4 2016 | $207,000 | -2.8% | 4,677 | +4.4% | 0.05% | +2.2% |
| Q3 2016 | $213,000 | -18.7% | 4,482 | -43.8% | 0.05% | -62.9% |
| Q3 2015 | $262,000 | -6.8% | 7,976 | +94.3% | 0.12% | -33.0% |
| Q1 2015 | $281,000 | – | 4,104 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |